Navigation
Home
Advocating for Access
Background
Letters for Access
Press Releases For Access
Simplified Community Materials
Simplified Community Materials
Understanding your HCV infection
Community Led Reports
Country Information
Indonesia
India
Vietnam
Generic DAAs Pricing
Resources
Guidelines
Key Research Publication
Other Important Documents and Reports
News
Gallery
Photos
Video
Stories
Simplified HCV Treatment* for Treatment-Naive Patients Without Cirrhosis
Simplified HCV Treatment* for Treatment-Naive Patients Without Cirrhosis
Download (PDF, 222KB)
December 3, 2019
/
Guidelines
,
News
Share
the Post
Related
Posts
Asia-Pacific Aids Groups Express Deep Dismay At Conclusion Of Secretly Negotiated Trans-Pacific Partnership Agreement That Threatens Future Access To Affordable Generic Medicines And Sustainable Development Goals
Four Indian generic companies take sub license from MPP on daclatasvir
Asia Pacific Situational Updates on Generic DAAs – June 2017
Pricing and availability of generic Indian Ledipasvir and Sofosbuvir co-formulation as on 26 April 2016
2018 IAS Brief Document Ending an Epidemic – Prioritizing People Who Inject Drugs in HCV elimination Efforts.
Up dated Generic Sofosbuvir availability and Price in India – 18 May 2015
Generic daclatasvir (60 mg) availability and India market pricing as of 30 January 2016
Response from CEO, CHAI about the Quick Start program in November 2016
